The hidden variable behind every reliable result? In every lab, there is one constant truth, your results are only as reliable as the conditions you create. While researchers spend countless…
The enzyme-linked immunosorbent assay (ELISA) remains a cornerstone technique in bioanalytical testing. From assessing pharmacokinetics and immunogenicity in biopharma to serving as the analytical backbone for many diagnostic assays, ELISA…
Meeting EMA & FDA Guidelines Introduction — why robust HCP detection matters now Biologic drugs and biosimilars depend on consistent, safe manufacturing. When E. coli is used as the expression…
When a diagnostic kit reaches a clinician or a point-of-care test station, the end user expects one thing above all: consistent, trustworthy results. For antigen-detection tests — especially for high-impact targets…
Introduction In the complex world of biopharma, diagnostics and clinical research, one process quietly drives accuracy and trust:bioanalytical method development. Whether it’s quantifying therapeutic antibodies, detecting biomarkers, or validating immunoassays, the enzyme-linked…
Introduction In the evolving world of in vitro diagnostics (IVD), where precision determines patient outcomes, recombinant proteins have become indispensable. Among them, Tumour Necrosis Factor Alpha (TNF-α) plays a critical role in developing and validating…
When it comes to antibody development — whether for diagnostics, therapeutics, or research — purity, specificity, and consistency are key. One of the most powerful methods to elevate antibody performance…
Biopharmaceuticals — from therapeutic proteins to vaccines — rely on recombinant expression systems. Yet one hidden challenge in production is the removal and quantification of host cell proteins (HCPs), which are…
In the in vitro diagnostics (IVD) world, a small leap in reagent quality can translate into significantly better test accuracy, lower costs, and higher trust. That leap increasingly depends on recombinant…
The Backbone of Reliable Diagnostics When clinical labs or diagnostic manufacturers deploy an assay, they trust that the reagents in #Batch A will behave the same as in #Batch B,…
In today’s fast-moving biopharma landscape, speed and reliability are non-negotiable. The ability to go from gene → expression → purification → functional protein is the foundation of drug discovery, diagnostics, and biologics…
Introduction When producing biotherapeutics—monoclonal antibodies, fusion proteins, or other recombinant products—the cells that make them matter almost as much as the product itself. In mammalian expression systems, CHO (Chinese Hamster Ovary) cells…
